Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
2 offices
Technology Company

Alastair George Sayce has worked on the following 6 EPO patent applications which have been published in the last five years:

EP12702009

NOVEL ANTIGEN BINDING PROTEINS

IPC classification:
C07K 16/22
Applicant:
Glaxo Group Limited
Agent:
Multiple attorneys, GlaxoSmithKline
Status:
EXAMINATION IN PROGRESS
EP12735498

THERAPEUTIC COMBINATIONS OF ANTI -CD20 AND ANTI - GM - CSF ANTIBODIES AND USES THEREOF

IPC classification:
A61K 39/395, C07K 16/24, C07K 16/28
Applicant:
MorphoSys AG
Agent:
Multiple attorneys, GlaxoSmithKline
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13784908

NOVEL ANTIBODIES

IPC classification:
A61K 39/395
Applicant:
GlaxoSmithKline LLC
Agent:
Multiple attorneys, GlaxoSmithKline
Status:
EXAMINATION IN PROGRESS
EP13732986

OPTIMUM DOSE REGIME OF AN ANTI-NOGO-A ANTIBODY IN THE TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS

IPC classification:
C07K 16/22
Applicant:
Glaxo Group Limited
Agent:
Multiple attorneys, GlaxoSmithKline
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP15155712

Antibody formulations

IPC classification:
A61K 9/00, A61K 39/395, C07K 16/00, C07K 16/28
Applicant:
Novartis AG
Applicant:
GlaxoSmithKline LLC
Agent:
Yixin Pfister-Fu, Novartis Pharma AG
Agent:
Alastair George Sayce, GlaxoSmithKline
Status:
EXAMINATION IN PROGRESS
EP12734212

NOVEL USES

IPC classification:
A61K 39/395
Applicant:
Novartis AG
Applicant:
GlaxoSmithKline Intellectual Property Development Limited
Agent:
Yixin Pfister-Fu, Novartis Pharma AG
Agent:
Alastair George Sayce, GlaxoSmithKline
Status:
EXAMINATION IN PROGRESS

Please Sign in to use this feature